SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS

BACKGROUND AND PURPOSE: Fibroblast growth factor 21 (FGF21) has recently been identified as a metabolic regulator, but its physiological role is still not completely known. The aim of this study was to evaluate serum FGF21 levels in an Iranian population with type 2 diabetes. MATERIALS AND METHODS:...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Acta Endocrinol (Buchar)
Huvudupphovsmän: Panahi, Y., Bonakdaran, S., Yaghoubi, M.A., Keramati, M.R., Haratian, M., Sahebkar, A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Acta Endocrinologica Foundation 2016
Ämnen:
General Endocrinology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535272/
https://ncbi.nlm.nih.gov/pubmed/31149098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2016.257
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk